BioSpace News Archive

Avadel Pharmaceuticals plc announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 17, 2022, to provide a corporate update and discuss the Company’s financial results for the fourth quarter and full year ended December 31, 2021.

Heat Biologics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, provided strategic, financial, and operational updates for the year ended December 31, 2021.

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), announced today that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of vonoprazan as a treatment for adults for the healing of all grades of erosive esophagitis (EE) and relief of heartburn, and maintenance of healing of all grades of EE and relief of heartburn.

Athenex, a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that the Company will provide a corporate and financial update for the fourth quarter and full year 2021, on Wednesday, March 16, 2022.

Chemomab Therapeutics, Ltd. (Nasdaq: CMMB) (Chemomab), today reported two scientific presentations last week that included preclinical and patient sample data supporting the potential utility of its lead therapeutic candidate, CM-101, as a novel therapy for the treatment of systemic sclerosis (SSc).

Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), today provides an update on plans for the further development of its lead compound fezagepras

Abcam plc, a global leader in the supply of life science research tools, announces its final results for the 18-month period ended 31 December 2021.

CAMP4 Therapeutics today announced that it has appointed Ann Barbier, M.D., Ph.D., as Chief Medical Officer, responsible for leading all clinical research and development, medical affairs and related functions.

StageZero Life Sciences, Ltd. announces that the Care Oncology Clinic service and COC Protocol is now available to patients living in Europe.

Arcturus Therapeutics Holdings Inc. announced that Company management will participate in a Fireside Chat at the Barclays Global Healthcare Conference on Wednesday, March 16, 2022 at 1:35 p.m. ET.